ArticleInternational journal of hematology2007

Long-term follow-up of busulfan, etoposide, and nimustine hydrochloride (ACNU) or melphalan as conditioning regimens for childhood acute leukemia and lymphoma.

Sakurako Izaki et al.PubMed ↗Publisher ↗

No numbers read from the abstract.